Clostridioides difficile is a bacterium that causes severe intestinal illness, but can be difficult to study and treat, and represents a significant public health issue. Studies in mice and in children carried out by researchers at Children’s Hospital of Philadelphia (CHOP) have now found that an opportunistic, antibiotic-resistant Enterococcus pathogen works together with C. difficile to reshape and enhance the metabolic environment in the gut so that C. difficile can thrive.
